Former Chief Medical Officer (9) · Harpoon Therapeutics, Inc. (HARP)

Natalie Sacks

A named executive officer of Harpoon Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$757,280

Salary $206,625Stock awards $0

FY2021: $2,675,862

3rd of 5 named executive officers at Harpoon Therapeutics by FY2022 total.

5 named officers on file for Harpoon Therapeutics, FY2022

Natalie Sacks’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Harpoon Therapeutics’s whole pay program stands against its peers

  • Harpoon Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on HARP→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2023 (DEF 14A).

Free

Get Natalie Sacks’s full pay file as a PDF — free

More than this page: up to 10 years of Natalie’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Natalie Sacks compensation by year

Harpoon Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Harpoon Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022
Salary$465,000$206,625
Bonus$0$0
Stock awards$0$0
Option awards$1,924,071$540,970
Non-equity incentive$277,050$0
Pension and deferred compensation$0$0
All other$9,741$9,685
Total$2,675,862$757,280

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Harpoon Therapeutics, Inc. DEF 14A filed April 27, 2023, accession 0001193125-23-122195, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Harpoon Therapeutics, Inc. filed document, accession 0001193125-23-122195. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2023.

$2.7M
$757K
FY21
FY22
SalaryNon-equity incentiveOption awardsAll other

Harpoon Therapeutics’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Holger WescheFormer Chief Science Officer (10)$1,432,904
Julie EastlandPresident, Chief Executive Officer and Director$1,160,774
Natalie Sacks · this pageFormer Chief Medical Officer (9)$757,280
Georgia ErbezFormer Chief Financial Officer (8)$727,847
Luke WalkerChief Medical Officer (7)$668,964

The full Harpoon Therapeutics compensation record

free company brief

This page is one person within Harpoon Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Harpoon Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Natalie Sacks's compensation dossier · One-time report. No refunds.